Best Topical therapy of melanoma Doctors Worldwide — TOP 23

Dr. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in complex melanoma treatments.

• Over 41 years of experience of experience in oncology
• Fellowship-trained at Institut Gustave Roussy in Paris
• Active member of ESMO's sarcoma faculty
• Published research on anti-melanoma antibodies
• Holds a clinical oncology associate professorship

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Dov Zippel is a surgical oncologist and head of the Meirav Breast Center. Forbes Israel named him to its Best Doctors list in 2025. He treats benign and malignant breast tumors and melanoma at Sheba Medical Center. Dr. Zippel completed a surgical oncology fellowship at the University of Calgary in Canada.

• Performs breast-conserving surgery and minimally invasive skin cancer procedures.
• Treats patients at the Ella Lemelbaum Institute for Immuno-Oncology.
• Researches perioperative treatments for stage III melanoma and breast lesion excision.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Mustafa Solak specializes in treating various cancers at Hisar Hospital Intercontinental, including melanoma.

• Completed fellowship at Hacettepe University Cancer Institute
• Handled many cases of breast, testicular, and ovarian cancers
• Trained at The University of Texas MD Anderson Cancer Center

Dr. Alemdar specializes in medical oncology with a focus on melanoma treatment at Medical Park Antalya Hospital Complex.

• Board-certified in medical oncology since 2018
• Extensive training at Akdeniz University Faculty of Medicine
• Over 20 years of experience of experience in internal medicine and oncology
• Works with advanced topical therapy techniques for melanoma

Dr. Soberino has played key roles in clinical trials leading to new melanoma treatments, including pioneering immunotherapies that transformed care.

• Specialist in immunotherapy for melanoma at Hospital Quiron Barcelona
• Contributed to trials approving Pembrolizumab and Nivolumab+Ipilimumab for melanoma
• Member of Vall d’Hebron’s Melanoma Unit, a leading oncology center
• Focuses on both breast cancer and melanoma treatment innovations

Dr. Shruti Kate specializes in melanoma therapy and has trained at Tata Memorial Hospital – one of India's top oncology centers.

• Expert in immunotherapy and metronomic therapy for advanced cancers
• Presented research at the World Conference on Lung Cancer
• Member of ASCO, ESMO, and other leading oncology societies
• DM in Medical Oncology from Tata Memorial Hospital

30 years of experience of experience with 50,000+ cancer surgeries – Dr. Raj Nagarkar specializes in Breast and Thoracic Surgical Oncology at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• Involved in 200+ clinical trials, including phase 1-3 studies
• Professor for DNB Superspecialty Surgical Oncology and Breast Surgery
• Focuses on improving patients' quality of life alongside treatment

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Dr. Shaunak Valame specializes in targeted therapies for melanoma, with research presented at the American Society of Clinical Oncology.

• Completed DNB in Medical Oncology from Indraprastha Apollo Hospital
• Presented research on stomach cancer at ASCO symposium
• Expert in molecular basis of cancer and targeted treatments
• Delivered lectures at International Winter School of Oncology

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Dr. Ahmer Arif Shaikh specializes in oral cancer and functional rehabilitation, with 15 years of experience of surgical oncology experience at HCG Manavata Cancer Centre.

• Expertise in organ preservation for oral cancer patients
• Proficient in major maxillofacial and head & neck surgeries
• Fellowship-trained in Head & Neck Surgical Oncology
• Researcher with multiple publications in the field

Dr. Lalit Banswal has performed over 10,000 major surgeries, specializing in minimally invasive cancer procedures with excellent outcomes.

• Fellowship-trained in surgical oncology at Tata Medical Centre, Kolkata
• Special focus on gastrointestinal cancer surgeries
• Co-principal investigator in multiple original research projects
• Known for patient-friendly and ethical approach